Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2002, p. 1101-1104, Vol. 46, No. 4
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.4.1101-1104.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Kazunori Oishi,1* Hiroyuki Yoshimine,1 Shoichi Suzuki,2 Atsushi Kumatori,2 Toshiaki Sunazuka,3 Satoshi Omura,3 Kouji Matsushima,4 and Tsuyoshi Nagatake1
Departments of Internal Medicine,1 Biochemistry, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523,2 The Kitasato Institute,3 Department of Molecular Preventive Medicine, The University of Tokyo, Tokyo, Japan4
Received 29 June 2001/ Returned for modification 15 October 2001/ Accepted 31 December 2001
A 14-member macrolide was found to inhibit interleukin-8 (IL-8) synthesis in lipopolysaccharide-stimulated neutrophils but did not accelerate apoptosis in activated neutrophils. These data suggest that 14-member macrolides achieve clinical efficacy for chronic airway diseases partly by suppressing IL-8 production by activated neutrophils, but not by enhancing apoptosis in these cells.
Present address: Pulmonary Department, National Sanatorium, Kawatana Hospital, 2005-1, Shimokumi, Kawatana 859-3615, Japan.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»